Evidence map›Paper›PMID 35184216›Full record

ArticleAnnals of nuclear medicine2022

Influence of antidepressant use on

Shinobu Adaniya, Miwako Takahashi, Keitaro Koyama, Kenichiro Ogane, Toshimitsu Momose

Open access · hybridAbstract read
In one paragraph

Article in Annals of nuclear medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Value of multi-parameterEJNMMI research · 2025
    Article
  2. Article
  3. Review
  4. Review
  5. Depression in dementia with Lewy bodies: a critical update.Journal of neural transmission (Vienna, Austria : 1996) · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Shinobu AdaniyaDepartment of Nuclear Medicine, Graduate School of Medicine, The International University of Health and Welfare, Narita, Japan.
Miwako TakahashiDepartment of Nuclear Medicine, Graduate School of Medicine, The International University of Health and Welfare, Narita, Japan. takahashi.miwako@qst.go.jp.ORCID http://orcid.org/0000-0002-1953-7428
Keitaro KoyamaDepartment of Nuclear Medicine, Graduate School of Medicine, The International University of Health and Welfare, Narita, Japan.
Kenichiro OganeDepartment of Nuclear Medicine, Graduate School of Medicine, The International University of Health and Welfare, Narita, Japan.
Toshimitsu MomoseDepartment of Nuclear Medicine, Graduate School of Medicine, The International University of Health and Welfare, Narita, Japan.
International University of Health and Welfare · JPNational Institutes for Quantum Science and Technology · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe clinical significance of decreased physiological lung uptake of

methodsWe retrospectively reviewed the heart and lung uptakes on 167 consecutive MIBG scans, antidepressant status, and clinical diagnosis of LBD. The images were visually classified into two groups: decreased lung uptake and preserved lung uptake. A semi-quantitative analysis was performed using the heart-to-mediastinum ratio (H/M), lung-to-mediastinum ratio (L/M), and myocardial washout rate (WR).

resultsAll 17 patients with decreased lung uptake were on treated with antidepressants, while none of the 150 patients with preserved lung uptake were treated with any antidepressants. Of the 17 patients with decreased lung uptake, 6 patients were clinically diagnosed as LBD and other 11 were clinically diagnosed as non-LBD. There was not significant difference in early H/M, delayed H/M, and myocardial WR between the 11 non-LBD patients with decreased lung uptake and 83 non-LBD patients with preserved lung uptake (2.87 ± 0.69 vs. 2.89 ± 0.44, 3.09 ± 0.48 vs. 2.98 ± 0.59, and 21.8 ± 11.3% vs. 21.1 ± 12.5%, respectively). Moreover, in LBD patients, there were no significant differences in those values between six patients with decreased lung uptake and 67 patients with preserved lung uptake (1.68 ± 0.32 vs. 1.73 ± 0.42, 1.34 ± 0.21 vs. 1.54 ± 0.57, 46.2 ± 22.8% vs. 42.8 ± 21.3%, respectively).

conclusionsAntidepressants probably blocked MIBG uptake in the lungs, and a decreased lung uptake was not significantly associated with heart uptake. A remarkable decrease in lung uptake can be a signal to check a patient's medication status.

Indexed as

3-IodobenzylguanidineLewy Body DiseaseAntidepressive AgentsHeartHumansIodine RadioisotopesLungRadiopharmaceuticalsRetrospective Studies3-IodobenzylguanidineAntidepressive AgentsIodine-123Iodine RadioisotopesRadiopharmaceuticalsAntidepressantLewy body diseaseLungMIBGSerotonin transporter

Identifiers

PMID35184216
PMCPMC9016011
OpenAlexW4212985406

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.